1.
J Fr Ophtalmol
; 45(1): e5-e6, 2022 Jan.
Article
in English
| MEDLINE
| ID: mdl-34384623
Subject(s)
Antibodies, Monoclonal, Humanized/adverse effects , Multiple Myeloma , Uveal Diseases , Uveal Effusion Syndrome , Antibodies, Monoclonal, Humanized/therapeutic use , Humans , Middle Aged , Multiple Myeloma/drug therapy , Neoplasm Recurrence, Local , Uveal Diseases/chemically induced , Uveal Effusion Syndrome/chemically induced
2.
Ann Intern Med
; 172(12): 834-836, 2020 06 16.
Article
in English
| MEDLINE
| ID: mdl-32150753